Eulalio A, Huntzinger E, Izaurralde E . Getting to the root of miRNA-mediated gene silencing. Cell 2008; 132: 9–14. ArticleCASPubMed Google Scholar
Kuchenbauer F, Morin RD, Argiropoulos B, Petriv OI, Griffith M, Heuser M et al. In-depth characterization of the microRNA transcriptome in a leukemia progression model. Genome Res 2008; 18: 1787–1797. ArticleCASPubMedPubMed Central Google Scholar
Farfsing A, Engel F, Seiffert M, Hartmann E, Ott G, Rosenwald A et al. Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia. Leukemia 2009; 23: 2018–2026. ArticleCASPubMed Google Scholar
Grasedieck S, Scholer N, Bommer M, Niess JH, Tumani H, Rouhi A et al. Impact of serum storage conditions on microRNA stability. Leukemia 2012; 26: 2414–2416. ArticleCASPubMed Google Scholar
Grasedieck S, Sorrentino A, Langer C, Buske C, Dohner H, Mertens D et al. Circulating microRNAs in hematological diseases: principles, challenges and perspectives. Blood 2013; 121: 4977–4984. ArticleCASPubMed Google Scholar
Rucker FG, Russ AC, Cocciardi S, Kett H, Schlenk RF, Botzenhardt U et al. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance. Leukemia 2013; 27: 353–361. ArticleCASPubMed Google Scholar
Kuchenbauer F, Mah SM, Heuser M, McPherson A, Ruschmann J, Rouhi A et al. Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells. Blood 2011; 118: 3350–3358. ArticleCASPubMed Google Scholar
Davis BN, Hata A . microRNA in Cancer—-The involvement of aberrant microRNA biogenesis regulatory pathways. Genes Cancer 2010; 1: 1100–1114. Article Google Scholar
Bhattacharya N, Diener S, Idler IS, Barth TF, Rauen J, Habermann A et al. Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood. Leukemia 2011; 25: 722–726. ArticleCASPubMed Google Scholar
Herman SE, Sun X, McAuley EM, Hsieh MM, Pittaluga S, Raffeld M et al. Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy. Leukemia 2013; e-pub ahead of print 26 April 2013 doi:10.1038/leu.2013.131. ArticleCASPubMedPubMed Central Google Scholar
Bullinger L, Leupolt E, Schaffner C, Mertens D, Bentz M, Lichter P et al. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma. Leukemia 2000; 14: 1490–1492. ArticleCASPubMed Google Scholar
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916. ArticleCASPubMed Google Scholar
Zenz T, Vollmer D, Trbusek M, Smardova J, Benner A, Soussi T et al. TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations. Leukemia 2010; 24: 2072–2079. ArticleCASPubMed Google Scholar
Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101–105. ArticleCASPubMedPubMed Central Google Scholar
Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011; 365: 2497–2506. ArticleCASPubMedPubMed Central Google Scholar
Stilgenbauer S, Nickolenko J, Wilhelm J, Wolf S, Weitz S, Dohner K et al. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 1998; 16: 1891–1897. ArticleCASPubMed Google Scholar
Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T . Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 2007; 21: 2442–2451. ArticleCASPubMed Google Scholar
Mertens D, Philippen A, Ruppel M, Allegra D, Bhattacharya N, Tschuch C et al. Chronic lymphocytic leukemia and 13q14: miRs and more. Leuk Lymphoma 2009; 50: 502–505. ArticleCASPubMed Google Scholar
Mertens D, Wolf S, Schroeter P, Schaffner C, Dohner H, Stilgenbauer S et al. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 2002; 99: 4116–4121. ArticleCASPubMed Google Scholar
Mertens D, Wolf S, Tschuch C, Mund C, Kienle D, Ohl S et al. Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism. Proc Natl Acad Sci USA 2006; 103: 7741–7746. ArticleCASPubMedPubMed Central Google Scholar
Garding A, Bhattacharya N, Claus R, Ruppel M, Tschuch C, Filarsky K et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia Is linked to the <italic>In Cis</italic> downregulation of a gene cluster that targets NF-kB. PLoS Genet 2013; 9: e1003373. ArticleCASPubMedPubMed Central Google Scholar
Allen JE, Hough RE, Goepel JR, Bottomley S, Wilson GA, Alcock HE et al. Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization. Br J Haematol 2002; 116: 291–298. ArticleCASPubMed Google Scholar
Sander S, Bullinger L, Leupolt E, Benner A, Kienle D, Katzenberger T et al. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations. Haematologica 2008; 93: 680–687. ArticleCASPubMed Google Scholar
Kohlhammer H, Schwaenen C, Wessendorf S, Holzmann K, Kestler HA, Kienle D et al. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood 2004 2004; 104: 795–801. ArticleCASPubMed Google Scholar
Lens D, Matutes E, Catovsky D, Coignet LJ . Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL). Leukemia 2000; 14: 427–430. ArticleCASPubMed Google Scholar
Corcoran MM, Hammarsund M, Zhu C, Lerner M, Kapanadze B, Wilson B et al. DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse. Genes Chromosomes Cancer 2004; 40: 285–297. ArticleCASPubMed Google Scholar
Mertens D, Stilgenbauer S . CLL and deletion 13q14: merely the miRs? Blood 2012; 119: 2974–2975. ArticleCASPubMed Google Scholar
Lerner M, Harada M, Loven J, Castro J, Davis Z, Oscier D et al. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res 2009; 315: 2941–2952. ArticleCASPubMed Google Scholar
Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T . Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853–858. ArticleCASPubMed Google Scholar
Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008; 105: 5166–5171. ArticleCASPubMedPubMed Central Google Scholar
Basso K, Sumazin P, Morozov P, Schneider C, Maute RL, Kitagawa Y et al. Identification of the human mature B cell miRNome. Immunity 2009; 30: 744–752. ArticleCASPubMedPubMed Central Google Scholar
Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010; 17: 28–40. ArticleCASPubMed Google Scholar
Lia M, Carette A, Tang H, Shen Q, Mo T, Bhagat G et al. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood 2012; 119: 2981–2990. ArticleCASPubMed Google Scholar
Shin VY, Jin H, Ng EK, Cheng AS, Chong WW, Wong CY et al. NF-kappaB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 2011; 32: 240–245. ArticleCASPubMed Google Scholar
Ofir M, Hacohen D, Ginsberg D . miR-15 and miR-16 Are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res 2011; 9: 440–447. ArticleCASPubMed Google Scholar
Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40: 43–50. ArticleCASPubMed Google Scholar
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524–15529. ArticleCASPubMedPubMed Central Google Scholar
Allegra D, Mertens D . In-vivo quantification of primary microRNA processing by Drosha with a luciferase based system. Biochem Biophys Res Commun 2011; 406: 501–505. ArticleCASPubMed Google Scholar
Raveche ES, Salerno E, Scaglione BJ, Manohar V, Abbasi F, Lin YC et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 2007; 109: 5079–5086. ArticleCASPubMedPubMed Central Google Scholar
Kim VN, Han J, Siomi MC . Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10: 126–139. ArticleCASPubMed Google Scholar
Edelmann J, Holzmann K, Miller F, Winkler D, Buhler A, Zenz T et al. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 2012; 120: 4783–4794. ArticleCASPubMed Google Scholar
Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 2010; 376: 1164–1174. ArticleCASPubMed Google Scholar
Garding A, Bhattacharya N, Haebe S, Muller F, Weichenhan D, Idler I et al. TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q. Haematologica 2013; 98: 269–273. ArticleCASPubMedPubMed Central Google Scholar
Dyer BW, Ferrer FA, Klinedinst DK, Rodriguez R . A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem 2000; 282: 158–161. ArticleCASPubMed Google Scholar
Kim YK, Yeo J, Kim B, Ha M, Kim VN . Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells. Mol Cell 2012; 46: 893–895. ArticleCASPubMed Google Scholar
Heale BS, Keegan LP, McGurk L, Michlewski G, Brindle J, Stanton CM et al. Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO J 2009; 28: 3145–3156. ArticleCASPubMedPubMed Central Google Scholar
Seifert M, Sellmann L, Bloehdorn J, Wein F, Stilgenbauer S, Durig J et al. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med 2012; 209: 2183–2198. ArticleCASPubMedPubMed Central Google Scholar
Stadler PF, Chen JJ, Hackermuller J, Hoffmann S, Horn F, Khaitovich P et al. Evolution of vault RNAs. Mol Biol Evol 2009; 26: 1975–1991. ArticleCASPubMed Google Scholar
Trabucchi M, Briata P, Garcia-Mayoral M, Haase AD, Filipowicz W, Ramos A et al. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009; 459: 1010–1014. ArticleCASPubMedPubMed Central Google Scholar
Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K et al. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol 2007; 9: 604–611. ArticleCASPubMed Google Scholar
Seiffert M, Stilgenbauer S, Dohner H, Lichter P . Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids. Leukemia 2007; 21: 1977–1983. ArticleCASPubMed Google Scholar
Stacchini A, Aragno M, Vallario A, Alfarano A, Circosta P, Gottardi D et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res 1999; 23: 127–136. ArticleCASPubMed Google Scholar
Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, Leoni LM et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004; 101: 3118–3123. ArticleCASPubMedPubMed Central Google Scholar
Gandhirajan RK, Staib PA, Minke K, Gehrke I, Plickert G, Schlosser A et al. Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. Neoplasia 2010; 12: 326–335. ArticleCASPubMedPubMed Central Google Scholar
Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O . miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 2010; 329: 1537–1541. ArticleCASPubMed Google Scholar
Lee J, Tattoli I, Wojtal KA, Vavricka SR, Philpott DJ, Girardin SE . pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J Biol Chem 2009; 284: 23818–23829. ArticleCASPubMedPubMed Central Google Scholar
Laxminarayana D, O'Rourke KS, Maas S, Olorenshaw I . Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes. Immunology 2007; 121: 359–369. ArticleCASPubMedPubMed Central Google Scholar
Xu M, Wells KS, Emeson RB . Substrate-dependent contribution of double-stranded RNA-binding motifs to ADAR2 function. Mol Biol Cell 2006; 17: 3211–3220. ArticleCASPubMedPubMed Central Google Scholar
Liu J, Chen G, Feng L, Zhang W, Pelicano H, Wang F et al. Loss of p53 and altered miR15-a/16-1short right arrowMCL-1 pathway in CLL: insights from TCL1-Tg:p53 mouse model and primary human leukemia cells. Leukemia 2013; e-pub ahead of print 23 April 2013 doi:10.1038/leu.2013.125. ArticleCASPubMedPubMed Central Google Scholar
Winter J, Jung S, Keller S, Gregory RI, Diederichs S . Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11: 228–234. ArticleCASPubMed Google Scholar
Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T . Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673–677. ArticleCASPubMed Google Scholar
Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 2009; 23: 2700–2704. ArticleCASPubMedPubMed Central Google Scholar
Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009; 41: 365–370. ArticleCASPubMedPubMed Central Google Scholar
Muralidhar B, Winder D, Murray M, Palmer R, Barbosa-Morais N, Saini H et al. Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles. J Pathol 2011 Mar, 14.
Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008; 68: 3566–3572. ArticleCASPubMed Google Scholar
Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K et al. ADAR1 Forms a complex with dicer to promote microRNA processing and RNA-induced gene silencing. Cell 2013; 153: 575–589. ArticleCASPubMedPubMed Central Google Scholar
Yang JH, Nie Y, Zhao Q, Su Y, Pypaert M, Su H et al. Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation. J Biol Chem 2003; 278: 45833–45842. ArticleCASPubMed Google Scholar
Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM et al. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nature Genet 2009; 41: 829–832. ArticleCASPubMed Google Scholar
Schuh A, Becq J, Humphray S, Alexa A, Burns A, Clifford R et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 2012; 120: 4191–4196. ArticleCASPubMed Google Scholar
Desterro JM, Keegan LP, Lafarga M, Berciano MT, O’Connell M, Carmo-Fonseca M . Dynamic association of RNA-editing enzymes with the nucleolus. J Cell Sci 2003; 116 (Pt 9): 1805–1818. ArticleCASPubMed Google Scholar
George CX, Gan Z, Liu Y, Samuel CE . Adenosine deaminases acting on RNA, RNA editing, and interferon action. J Interferon Cytokine Res 2011; 31: 99–117. ArticleCASPubMedPubMed Central Google Scholar